A Breath of Fresh Air
A young, athletic woman has her breath taken away—literally—only to find a new lease on life with new lungs.
Nathaniel Langer, MD, MSc, is a board-certified adult cardiac surgeon at the Massachusetts General Hospital, an Assistant Professor of Surgery at Harvard Medical School, and a member of the Corrigan Minehan Heart Center. His practice focuses on transcatheter aortic valve replacement (TAVR) and minimally invasive treatment of heart valve disease, as well pulmonary thromboendarterectomy and coronary artery bypass grafting.Dr. Langer received his medical degree (MD) from Columbia University's Vagelos College of Physicians and Surgeons and his Master of Science (MSc) degree from Paris-Sud University in Paris, France. He completed his internship, residency, and chief residency in cardiothoracic surgery at New York-Presbyterian Hospital/Columbia University Irving Medical Center. Dr. Langer's research interests include clinical outcomes in adult cardiac surgery, as well as right ventricular metabolism and right ventricular failure in patients with pulmonary hypertension.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Mass General Heart Center: Cardiac Surgery
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2593
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
The focus of my research is on clinical outcomes in adult cardiac surgery, specifically following transcatheter aortic valve replacement (TAVR) and complex cardiac surgical procedures. I also study right ventricular failure in patients with pulmonary hypertension.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
A young, athletic woman has her breath taken away—literally—only to find a new lease on life with new lungs.
Massachusetts General Hospital (MGH) is announcing two first-of-their-kind procedures in New England today, to treat one of the most common forms of heart valve disease.